GB1501591A - Composition containing 1,3-bis-((p-chlorobenzylidene)-amino)-guanidine - Google Patents
Composition containing 1,3-bis-((p-chlorobenzylidene)-amino)-guanidineInfo
- Publication number
- GB1501591A GB1501591A GB613/76A GB61376A GB1501591A GB 1501591 A GB1501591 A GB 1501591A GB 613/76 A GB613/76 A GB 613/76A GB 61376 A GB61376 A GB 61376A GB 1501591 A GB1501591 A GB 1501591A
- Authority
- GB
- United Kingdom
- Prior art keywords
- water
- protective colloid
- amino
- colloid
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- MOOFYEJFXBSZGE-LQGKIZFRSA-N 1,2-bis[(e)-(4-chlorophenyl)methylideneamino]guanidine Chemical compound C=1C=C(Cl)C=CC=1\C=N\N=C(/N)N\N=C\C1=CC=C(Cl)C=C1 MOOFYEJFXBSZGE-LQGKIZFRSA-N 0.000 title 1
- 239000000084 colloidal system Substances 0.000 abstract 6
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 4
- 230000001681 protective effect Effects 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- MOOFYEJFXBSZGE-QJUDHZBZSA-N 1,2-bis[(z)-(4-chlorophenyl)methylideneamino]guanidine Chemical compound C=1C=C(Cl)C=CC=1\C=N/N=C(/N)N\N=C/C1=CC=C(Cl)C=C1 MOOFYEJFXBSZGE-QJUDHZBZSA-N 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 229960004591 robenidine Drugs 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- XJSNBPJINGRLAM-UHFFFAOYSA-N 5-[(3-bromo-4,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound BrC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 XJSNBPJINGRLAM-UHFFFAOYSA-N 0.000 abstract 1
- KEEYRKYKLYARHO-UHFFFAOYSA-N 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine Chemical compound C1=C(OC)C(OC)=CC(C)=C1CC1=CN=C(N)N=C1N KEEYRKYKLYARHO-UHFFFAOYSA-N 0.000 abstract 1
- PVQOGQNECOHWIH-UHFFFAOYSA-N 5-[(4-chlorophenyl)methyl]-6-ethylpyrimidine-2,4-diamine Chemical compound CCC1=NC(N)=NC(N)=C1CC1=CC=C(Cl)C=C1 PVQOGQNECOHWIH-UHFFFAOYSA-N 0.000 abstract 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 abstract 1
- 244000215068 Acacia senegal Species 0.000 abstract 1
- 235000006491 Acacia senegal Nutrition 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- PJSFRIWCGOHTNF-UHFFFAOYSA-N Sulphormetoxin Chemical compound COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC PJSFRIWCGOHTNF-UHFFFAOYSA-N 0.000 abstract 1
- 241000589634 Xanthomonas Species 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 230000000842 anti-protozoal effect Effects 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 239000003904 antiprotozoal agent Substances 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- LDBTVAXGKYIFHO-UHFFFAOYSA-N diaveridine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=CN=C(N)N=C1N LDBTVAXGKYIFHO-UHFFFAOYSA-N 0.000 abstract 1
- 229950000246 diaveridine Drugs 0.000 abstract 1
- 239000012895 dilution Substances 0.000 abstract 1
- 238000010790 dilution Methods 0.000 abstract 1
- 239000004491 dispersible concentrate Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- -1 p - chlorobenzylidene Chemical group 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 abstract 1
- 229960000611 pyrimethamine Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 229960004306 sulfadiazine Drugs 0.000 abstract 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 abstract 1
- ZZORFUFYDOWNEF-UHFFFAOYSA-N sulfadimethoxine Chemical compound COC1=NC(OC)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ZZORFUFYDOWNEF-UHFFFAOYSA-N 0.000 abstract 1
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 abstract 1
- 229960005404 sulfamethoxazole Drugs 0.000 abstract 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 abstract 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 abstract 1
- 229960001082 trimethoprim Drugs 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL46406A IL46406A (en) | 1975-01-08 | 1975-01-08 | The water-floating mixture containing robinidin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1501591A true GB1501591A (en) | 1978-02-15 |
Family
ID=11048013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB613/76A Expired GB1501591A (en) | 1975-01-08 | 1976-01-08 | Composition containing 1,3-bis-((p-chlorobenzylidene)-amino)-guanidine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4041160A (enExample) |
| JP (1) | JPS5195122A (enExample) |
| DE (1) | DE2600004A1 (enExample) |
| ES (1) | ES444286A1 (enExample) |
| FR (1) | FR2297036A1 (enExample) |
| GB (1) | GB1501591A (enExample) |
| IL (1) | IL46406A (enExample) |
| ZA (1) | ZA766B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK136934B (da) * | 1976-02-06 | 1977-12-19 | Rosco As | Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator. |
| EP2991638B1 (en) | 2013-05-01 | 2019-06-26 | Neoculi Pty Ltd | Methods for treating bacterial infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2904469A (en) * | 1957-07-29 | 1959-09-15 | Johnson & Johnson | Stabilized aqueous suspension of salicylamide |
| US3901944A (en) * | 1972-05-08 | 1975-08-26 | American Cyanamid Co | 1,3-bis(substituted benzylideneamino)guanidines |
-
1975
- 1975-01-08 IL IL46406A patent/IL46406A/en unknown
- 1975-12-30 US US05/645,379 patent/US4041160A/en not_active Expired - Lifetime
-
1976
- 1976-01-02 ZA ZA6A patent/ZA766B/xx unknown
- 1976-01-06 DE DE19762600004 patent/DE2600004A1/de active Pending
- 1976-01-07 JP JP51001827A patent/JPS5195122A/ja active Pending
- 1976-01-08 FR FR7600313A patent/FR2297036A1/fr active Granted
- 1976-01-08 ES ES444286A patent/ES444286A1/es not_active Expired
- 1976-01-08 GB GB613/76A patent/GB1501591A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5195122A (enExample) | 1976-08-20 |
| ES444286A1 (es) | 1977-05-16 |
| FR2297036A1 (fr) | 1976-08-06 |
| IL46406A0 (en) | 1975-04-25 |
| DE2600004A1 (de) | 1976-07-15 |
| ZA766B (en) | 1977-01-26 |
| US4041160A (en) | 1977-08-09 |
| IL46406A (en) | 1977-08-31 |
| FR2297036B1 (enExample) | 1978-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI93309B (fi) | Menetelmä stabiilin sinkki-protamiini- -interferonikompleksin valmistamiseksi | |
| GB1132474A (en) | Method for the preparation of thiogold (i) compounds | |
| YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
| RU94027576A (ru) | Производные 1-бензолсульфонил-1,3-дигидро-индол-2-она, способ их получения и содержащие их фармацевтические композиции | |
| HUP9802086A2 (hu) | Piperidino-alkanol vegyületeket tartalmazó gyógyszerkészítmények | |
| DE60233137D1 (de) | Transporter mit beabstandeten arginin-teilchen | |
| GB1131007A (en) | Improvements in or relating to aqueous solutions of oxytetracycline | |
| HUP9802394A2 (hu) | Szulfatált oligoszacharidok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények | |
| CA2057291A1 (en) | A stable pharmaceutical composition of human calcitonin | |
| IT1226727B (it) | Farmaci precursori della dopamina. | |
| KR900011754A (ko) | (디-3급-부틸히드록시페닐)티오 유도체 | |
| NO307570B1 (no) | Inklusjonskomplekser oppnådd fra nimesulidalkali- og nimesulidjordalkalisalter og cyklodekstriner eller cyklodekstrinderivater, samt farmasøytisk preparat inneholdende nevnte inklusjonskompleks og fremgangsmåte for å fremstille samme | |
| KR950700326A (ko) | 파라토르몬 단편, 이것의 제조방법 및 이것을 함유하는 약제(parathyroid hormone fragments, their preparation and medicaments containing the same) | |
| GB1501591A (en) | Composition containing 1,3-bis-((p-chlorobenzylidene)-amino)-guanidine | |
| ATA147791A (de) | Pharmazeutische pleuromutilin-zubereitung | |
| KR840002345A (ko) | 니트로 안식향산 아미드 유도체 | |
| AU8295587A (en) | Nasal solutions | |
| JP2688057B2 (ja) | 抗腺がん剤 | |
| GB1331190A (en) | X-ray contrast composition containing barium sulphate | |
| GB1290381A (enExample) | ||
| GB1510651A (en) | Photographic processes and silver halide solvent compositions | |
| Hahn et al. | Effects of inflammation (turpentine abscess) on iron absorption | |
| NO914650D0 (no) | Inklusjonskomplekser av 3-morfolino-sydnonimin eller detstautomer-isomer, fremgangsmaate for fremstilling av disse og farmasoeytiske preparater inneholdende disse | |
| JPH02240025A (ja) | 安定な複合ビタミン水溶液 | |
| AU5024599A (en) | Pharmaceutical composition with antitumor activity on the basis of carboplatin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |